Literature DB >> 14744860

Ribosome stalling during translation elongation induces cleavage of mRNA being translated in Escherichia coli.

Takafumi Sunohara1, Kaoru Jojima, Hideaki Tagami, Toshifumi Inada, Hiroji Aiba.   

Abstract

Recently, it has been found that ribosome pausing at stop codons caused by certain nascent peptides induces cleavage of mRNA in Escherichia coli cells (1, 2). The question we addressed in the present study is whether mRNA cleavage occurs when translation elongation is prevented. We focused on a specific peptide sequence (AS17), derived from SecM, that is known to cause elongation arrest. When the crp-crr fusion gene encoding CRP-AS17-IIA(Glc) was expressed, cAMP receptor protein (CRP) proteins truncated around the arrest sequence were efficiently produced, and they were tagged by the transfer-messenger RNA (tmRNA) system. Northern blot analysis revealed that both truncated upstream crp and downstream crr mRNAs were generated along with reduced amounts of the full-length crp-crr mRNA. The truncated crp mRNA dramatically decreased in the presence of tmRNA due to rapid degradation. The 3' ends of truncated crp mRNA correspond well to the C termini of the truncated CRP proteins. We conclude that ribosome stalling by the arrest sequence induces mRNA cleavage near the arrest point, resulting in nonstop mRNAs that are recognized by tmRNA. We propose that the mRNA cleavage induced by ribosome stalling acts in concert with the tmRNA system as a way to ensure quality control of protein synthesis and possibly to regulate the expression of certain genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744860     DOI: 10.1074/jbc.M312805200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Translation arrest of SecM is essential for the basal and regulated expression of SecA.

Authors:  Akiko Murakami; Hitoshi Nakatogawa; Koreaki Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

2.  Importance of the tmRNA system for cell survival when transcription is blocked by DNA-protein cross-links.

Authors:  H Kenny Kuo; Rachel Krasich; Ashok S Bhagwat; Kenneth N Kreuzer
Journal:  Mol Microbiol       Date:  2010-09-16       Impact factor: 3.501

Review 3.  Divergent stalling sequences sense and control cellular physiology.

Authors:  Koreaki Ito; Shinobu Chiba; Kit Pogliano
Journal:  Biochem Biophys Res Commun       Date:  2010-02-01       Impact factor: 3.575

Review 4.  All things must pass: contrasts and commonalities in eukaryotic and bacterial mRNA decay.

Authors:  Joel G Belasco
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-03       Impact factor: 94.444

5.  Under the Tucson sun: a meeting in the desert on mRNA decay.

Authors:  Kristian E Baker; Ciarán Condon
Journal:  RNA       Date:  2004-11       Impact factor: 4.942

6.  SecM facilitates translocase function of SecA by localizing its biosynthesis.

Authors:  Hitoshi Nakatogawa; Akiko Murakami; Hiroyuki Mori; Koreaki Ito
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

7.  Prolyl-tRNA(Pro) in the A-site of SecM-arrested ribosomes inhibits the recruitment of transfer-messenger RNA.

Authors:  Fernando Garza-Sánchez; Brian D Janssen; Christopher S Hayes
Journal:  J Biol Chem       Date:  2006-09-12       Impact factor: 5.157

8.  Protein tagging at rare codons is caused by tmRNA action at the 3' end of nonstop mRNA generated in response to ribosome stalling.

Authors:  Xia Li; Rieko Hirano; Hideaki Tagami; Hiroji Aiba
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

9.  Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation.

Authors:  Meenakshi K Doma; Roy Parker
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

10.  Transfer-messenger RNA controls the translation of cell-cycle and stress proteins in Streptomyces.

Authors:  Sharief Barends; Martin Zehl; Sylwia Bialek; Ellen de Waal; Bjørn A Traag; Joost Willemse; Ole Nørregaard Jensen; Erik Vijgenboom; Gilles P van Wezel
Journal:  EMBO Rep       Date:  2009-12-18       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.